Ingredion grants 371 director shares as part of annual retainer

Ingredion Inc. reported that one of its directors acquired additional common stock through an equity grant.

Accepted by SEC EDGAR 12/09/2025 - 06:03 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Ingredion Inc. reported that one of its directors acquired additional common stock through an equity grant. On 12/05/2025, the director received 371 shares of Ingredion common stock at a price of $107.70 per share, recorded as an acquisition. These shares were issued to the company’s outside directors as part of their annual retainer, meaning they are a form of stock-based compensation rather than an open-market purchase.

Following this grant, the director beneficially owns 1,557 shares of common stock directly and 8,800 shares indirectly through The Tanda Joint Living Trust. The filing is a standard Form 4 disclosure showing updated ownership levels for a board member tied to routine director compensation.

Insider Trade Summary

Grant/Award: 371 shares

Grant/Award 1 txn

Insider Tanda Stephan B.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	371	$107.70	$40K
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,557 shares (Direct); Common Stock — 8,800 shares (Indirect, through The Tanda Joint Living Trust)

Footnotes (1)

1. F1. These are shares of common stock issued to the Company's outside directors as part of their annual retainer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Ingredion (INGR) disclose in this Form 4 filing?

Ingredion disclosed that a director received 371 shares of common stock on 12/05/2025 as part of the annual retainer for outside directors.

What price was used for the director share grant at Ingredion (INGR)?

The director’s 371 shares of Ingredion common stock were recorded at a price of $107.70 per share.

How many Ingredion (INGR) shares does the director own after this transaction?

After the transaction, the director beneficially owns 1,557 shares directly and 8,800 shares indirectly through The Tanda Joint Living Trust.

Why did the Ingredion (INGR) director receive these shares?

The 371 shares were issued as common stock to the company’s outside directors as part of their annual retainer, representing stock-based compensation for board service.

Is this Ingredion (INGR) Form 4 related to derivative securities?

The filing includes a table for derivative securities, but in this disclosure there are no derivative securities reported as acquired or disposed of.

How is indirect ownership reported for the Ingredion (INGR) director?

The filing shows 8,800 shares of Ingredion common stock held indirectly through The Tanda Joint Living Trust, in addition to directly owned shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tanda Stephan B.

(Last) (First) (Middle)

5 WESTBROOK CORPORATE CENTER

(Street)

WESTCHESTER IL 60154

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ingredion Inc [ INGR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/05/2025		A		371(1)	A	$107.7	1,557	D
Common Stock								8,800	I	through The Tanda Joint Living Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These are shares of common stock issued to the Company's outside directors as part of their annual retainer.

	Michael N. Levy, attorney-in-fact	12/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.